These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

886 related articles for article (PubMed ID: 11839570)

  • 1. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
    Joussen AM; Poulaki V; Qin W; Kirchhof B; Mitsiades N; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    Am J Pathol; 2002 Feb; 160(2):501-9. PubMed ID: 11839570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of diabetic retinopathy with angiopoietin-1.
    Joussen AM; Poulaki V; Tsujikawa A; Qin W; Qaum T; Xu Q; Moromizato Y; Bursell SE; Wiegand SJ; Rudge J; Ioffe E; Yancopoulos GD; Adamis AP
    Am J Pathol; 2002 May; 160(5):1683-93. PubMed ID: 12000720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression.
    Joussen AM; Poulaki V; Mitsiades N; Kirchhof B; Koizumi K; Döhmen S; Adamis AP
    FASEB J; 2002 Mar; 16(3):438-40. PubMed ID: 11821258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes.
    Barouch FC; Miyamoto K; Allport JR; Fujita K; Bursell SE; Aiello LP; Luscinskas FW; Adamis AP
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1153-8. PubMed ID: 10752954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
    Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
    Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
    Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF164 is proinflammatory in the diabetic retina.
    Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes.
    Miyahara S; Kiryu J; Yamashiro K; Miyamoto K; Hirose F; Tamura H; Katsuta H; Nishijima K; Tsujikawa A; Honda Y
    Am J Pathol; 2004 May; 164(5):1697-706. PubMed ID: 15111316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
    Hattori T; Matsubara A; Taniguchi K; Ogura Y
    Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor.
    El-Remessy AB; Behzadian MA; Abou-Mohamed G; Franklin T; Caldwell RW; Caldwell RB
    Am J Pathol; 2003 Jun; 162(6):1995-2004. PubMed ID: 12759255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor up-regulates the expression of intracellular adhesion molecule-1 in retinal endothelial cells via reactive oxygen species, but not nitric oxide.
    Zhang XL; Wen L; Chen YJ; Zhu Y
    Chin Med J (Engl); 2009 Feb; 122(3):338-43. PubMed ID: 19236815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
    Gilbert RE; Vranes D; Berka JL; Kelly DJ; Cox A; Wu LL; Stacker SA; Cooper ME
    Lab Invest; 1998 Aug; 78(8):1017-27. PubMed ID: 9714188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.
    Poulaki V; Qin W; Joussen AM; Hurlbut P; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    J Clin Invest; 2002 Mar; 109(6):805-15. PubMed ID: 11901189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
    Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of a coumarin derivative in diabetic rats.
    Bucolo C; Ward KW; Mazzon E; Cuzzocrea S; Drago F
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3846-52. PubMed ID: 19279317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF increases retinal vascular ICAM-1 expression in vivo.
    Lu M; Perez VL; Ma N; Miyamoto K; Peng HB; Liao JK; Adamis AP
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1808-12. PubMed ID: 10393052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
    Cui B; Sun JH; Xiang FF; Liu L; Li WJ
    Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S
    Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice.
    Brooks SE; Gu X; Samuel S; Marcus DM; Bartoli M; Huang PL; Caldwell RB
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):222-8. PubMed ID: 11133872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.